Two Paraneoplastic Syndromes in a Patient with Ovarian Cancer: Nephrotic Syndrome and Paraneoplastic Cerebellar Degeneration

2001 ◽  
Vol 80 (1) ◽  
pp. 96-98 ◽  
Author(s):  
Andrea P. Forgy ◽  
Thomas L. Ewing ◽  
John Flaningam
2020 ◽  
Vol 34 ◽  
pp. 100649
Author(s):  
Takashi Shibata ◽  
Tetsuya Oishi ◽  
Yasunori Fukuoka ◽  
Shigeki Nishikawa ◽  
Noriaki Iizuka ◽  
...  

2008 ◽  
Vol 280 (1) ◽  
pp. 99-101 ◽  
Author(s):  
Bram H. Goldstein ◽  
Connie L. Birk ◽  
Mark Van Houten ◽  
Robert Veve ◽  
John V. Brown ◽  
...  

2020 ◽  
Vol 36 (1) ◽  
pp. 34-36
Author(s):  
Navin Kumar ◽  
Mukurdipi Ray ◽  
Kanak Lata ◽  
Durgesh Wankhede ◽  
Sandeep R. Mathur ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-3 ◽  
Author(s):  
Allison N. Martin ◽  
Patrick M. Dillon ◽  
David E. Jones ◽  
David R. Brenin ◽  
David A. Lapides

Paraneoplastic cerebellar degeneration (PCD) is a rare anti-Yo mediated paraneoplastic syndromes rarely that is infrequently associated with breast cancer. We present a case of a 52-year-old female presenting with diplopia, gait instability, dysarthria, dysphagia, nystagmus, and, most notably, new onset paroxysmal episodes of uncontrollable crying concerning for pseudobulbar affect (PBA). Serologic testing showed anti-Yo antibodies. The patient was found to have stage IIIA breast cancer as the inciting cause of the paraneoplastic syndrome. The patient was treated with neoadjuvant chemotherapy, modified radical mastectomy, adjuvant Herceptin, and pertuzumab. She was given IVIG for paraneoplastic syndrome, antidepressants, and dextromethorphan-quinidine (Nuedexta), the first FDA-approved therapy for PBA. With multimodality therapy, she demonstrated significant improvement in neurologic and mood symptoms associated with PCD and PBA.


2012 ◽  
Vol 5 (2) ◽  
pp. 681-683 ◽  
Author(s):  
ALESSIA ERIKA RUSSO ◽  
SIMONA SCALONE ◽  
GIULIA COSTANZA LEONARDI ◽  
AURORA SCALISI ◽  
GIORGIO GIORDA ◽  
...  

Author(s):  
Hayat Erraichi ◽  
Niaina Ezra Randriamanovontsoa ◽  
Valère Litique ◽  
Jean-Marc Limacher ◽  
S. Berrad ◽  
...  

Neurological paraneoplastic syndromes are rare, often associated with gynecological cancer or small cell lung cancer. This article reports a case of ovarian cancer to discuss the difficulties in the management of neurological paraneoplastic syndromes. This is a case of paraneoplastic cerebellar syndrome with anti-Yo antibodies. Neurological syndromes, testing for onconeural antibodies and testing for underlying cancer provide a basis for the diagnosis. The anti-tumor treatment constitutes the mainstay of the care.


2014 ◽  
Vol 18 ◽  
Author(s):  
Fadwa Elomrani ◽  
Imane Ouziane ◽  
Saber Boutayeb ◽  
Youssef Bensouda ◽  
Hind Mrabti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document